Pfizer CEO Albert Bourla wins $1 million Genesis Prize for COVID-19 vaccine development
The global pharmaceutical giant Pfizer Inc.’s Chairman and Chief Executive, Albert Bourla, has been awarded with the prestigious Genesis Prize 2022 on January 19, 2022.
He has been awarded for his efforts in leading the development of a COVID-19 vaccine (Pfizer–BioNTech COVID-19 vaccine).
The award comes with cash prize of $1 million.
The annual prize is awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values and/or to the State of Israel.
It is widely referred to as the “Jewish Nobel Prize”